Sunday
2:00 pm - 9:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Staff / Welcome and Introduction from the Chairs
7:40 pm - 9:30 pm
Keynote Session: EV-Based Biomarkers and Therapies: Identifying Molecular Mechanisms
7:40 pm - 7:50 pm
Introduction by Discussion Leader
7:50 pm - 8:20 pm
"Molecular Mechanisms of Secretomes from Perinatal Tissues for Anti-Inflammatory Therapies"
8:20 pm - 8:40 pm
Discussion
8:40 pm - 9:10 pm
"Oncogenes and Extracellular Vesicles in Cancer"
9:10 pm - 9:30 pm
Discussion
Monday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Novel Concepts for EV-Based Therapeutics
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
"Targeting Tumor Plasticity Using Extracellular Vesicle-Based Therapies"
9:35 am - 9:50 am
Discussion
9:50 am - 10:20 am
"Targeted and Programmable Delivery of Genome Editors for Developing EV-Based Gene Therapy"
10:20 am - 10:35 am
Discussion
10:35 am - 11:05 am
Coffee Break
11:05 am - 11:35 am
"Leukotrienes in Extracellular Vesicle-Mediated Immune Activation"
11:35 am - 11:50 am
Discussion
11:50 am - 12:05 pm
Short Talk Selected from Poster Abstracts
12:05 pm - 12:15 pm
Discussion
12:15 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
EVs as Promising Tools in Biomarker Discovery
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"Kindlin-2 Regulates Extracellular Vesicle–Mediated Invasion and Immune Escape in Triple-Negative Breast Cancer"
6:30 pm - 6:45 pm
Discussion
6:45 pm - 7:10 pm
"Extracellular Vesicle Heterogeneity and Biomarker Discovery"
7:10 pm - 7:25 pm
Discussion
7:25 pm - 7:40 pm
Short Talk Selected from Poster Abstracts
7:40 pm - 7:50 pm
Discussion
7:50 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Tuesday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Group Photo
9:00 am - 12:30 pm
In-vitro and In-vivo Model-Systems for EV Characterization
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
"From Lung to Clot: Predicting and Preventing Cancer-Associated Thrombosis via Extracellular Vesicle Targeting"
9:35 am - 9:50 am
Discussion
9:50 am - 10:20 am
"Different Messages, Different Packages: The RNA of Extracellular Vesicles and Nanoparticles"
10:20 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:30 am
"Organs-on-a-Chip to Unveil EV Signaling in Malaria Parasites"
11:30 am - 11:45 am
Discussion
11:45 am - 12:00 pm
Short Talk Selected from Poster Abstracts
12:00 pm - 12:10 pm
Discussion
12:10 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Towards EV-Potency Assay Development
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"The Gaps You Need to Fill from Science to Product Profile"
6:30 pm - 6:45 pm
Discussion
6:45 pm - 7:10 pm
"Non-Coding RNAs in Extracellular Vesicles from Natural Killer Cells as Cancer Immune Effectors"
7:10 pm - 7:25 pm
Discussion
7:25 pm - 7:40 pm
Short Talk Selected from Poster Abstracts
7:40 pm - 7:50 pm
Discussion
7:50 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Meet the Hurdle: Regulatory Aspects in EV Therapeutics Development
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
"An Innovative Platform for Translatable and Scalable Therapeutics: RNA‑Based Therapies Delivered via Engineered Red Blood Cell‑Derived Extracellular Vesicles"
9:35 am - 9:50 am
Discussion
9:50 am - 10:20 am
"Exploring Intranasal Milk EV-Based Therapy to Treat Preterm Brain Injury"
10:20 am - 10:35 am
Discussion
10:35 am - 11:05 am
Coffee Break
11:05 am - 11:35 am
"Systems-Level Multi-Omics of Stem Cell–Derived RPE: A Roadmap for Precision Ocular Therapeutics, Mechanism of Action and Beyond"
11:35 am - 11:50 am
Discussion
11:50 am - 12:05 pm
Short Talk Selected from Poster Abstracts
12:05 pm - 12:15 pm
Discussion
12:15 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Utilizing EVs in Biomedical Applications
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"Spatial Understanding of Extracellular Vesicle Heterogeneity in Cancer Patients"
6:30 pm - 6:45 pm
Discussion
6:45 pm - 7:10 pm
"Quantifying the Relative Contribution of Tissues to the Circulating Pool of Extracellular Vesicles"
7:10 pm - 7:25 pm
Discussion
7:25 pm - 7:40 pm
Short Talk Selected from Poster Abstracts
7:40 pm - 7:50 pm
Discussion
7:50 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Thursday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Business Meeting
Nominations for the Next Vice Chair(s); Complete the GRC Evaluation Forms; Election of the Next Vice Chair(s)
9:00 am - 12:30 pm
Exploiting EV Biology and Functions for Therapeutics or Diagnostics
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
"Tumor Promoting Effects of Glioma EV and Their Modulation for Immunotherapy"
9:35 am - 9:50 am
Discussion
9:50 am - 10:20 am
"Exploiting our Understanding of EV Biology to Develop Clinically Validated Cancer Biomarkers"
10:20 am - 10:35 am
Discussion
10:35 am - 11:05 am
Coffee Break
11:05 am - 11:35 am
"Functional Heterogeneity of EVs"
11:35 am - 11:50 am
Discussion
11:50 am - 12:05 pm
Short Talk Selected from Poster Abstracts
12:05 pm - 12:15 pm
Discussion
12:15 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Ongoing Clinical Studies Investigating EV-Based Therapeutics and Initial Results
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"ESCRT Clinical Trial: Preliminary Results from the First-in-Human Clinical Trial on EVs in Cochlear Implantation"
6:30 pm - 6:45 pm
Discussion
6:45 pm - 7:10 pm
"GMP-Compliant Process for the Manufacturing of an Extracellular Vesicles-Enriched Secretome Product Derived From Cardiovascular Progenitor Cells Suitable for a Phase I Clinical Trial"
7:10 pm - 7:25 pm
Discussion
7:25 pm - 7:40 pm
Short Talk Selected from Poster Abstracts
7:40 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
General Discussion
7:55 pm - 8:00 pm
Closing Remarks
8:00 pm - 9:00 pm
Dinner
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure